Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial

Klaus F. Rabe, Bartolomé R. Celli, Michael E. Wechsler, Raolat M. Abdulai, Xiaodong Luo, Maarten M. Boomsma, Heribert Staudinger, Julie Horowitz, Aris Baras, Manuel A. R. Ferreira, Marcella Ruddy, Michael C. Nivens, Nikhil Amin, David M. Weinreich, George D. Yancopoulos, Hélène Goulaouic